A clinical results graphic is circulating: Peptaxel, 9 weeks, 20 women, average age 55. The spicule delivery science behind it is real and well documented. The human outcome data is thinner than the marketing suggests — and not one line of that study accounts for the variable that matters most in a cohort that age: hormonal status.

In aesthetics, exosome therapy is gaining popularity because it offers many of the regenerative benefits of stem cells—like stimulating collagen, repairing damaged skin, and reducing inflammation—without the ethical concerns or complex harvesting process. This makes exosomes a safer, more targeted option for treatments such as microneedling, laser resurfacing, and anti-aging facials.

So, while stem cells provide the source, exosomes deliver the action. Choosing treatments that incorporate exosomes can accelerate healing, improve skin texture, and enhance overall results.